WANDA BEARING
920002
JUNCHUANG TECH
833533
SanFeng Intelligent Equipment Group
300276
4
Dioo Microcircuits
688381
5
Est Tools Co., Ltd.
300488
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.